Seeking Alpha: How Bad Will The Partial Hold On Sovaprevir Be For Achillion?

Achillion ( ACHN ) investors got a huge piece of bad news on Monday evening, when this biotech virology specialist announced that its lea...

Seeking Alpha: Volcano Still Has Plenty To Prove

Volcano ( VOLC ) has never been shy about setting ambitious targets or pursuing a bold vision for the company's future. Unfortunately...

Seeking Alpha: Achillion May Be The Most Underrated Biotech Left

There are broadly two types of biotech investors - the Wile E. Coyote types who see bargains everywhere and charge bravely after them and t...